APPLICATION
ANDA088331
TYPE
ANDA
ORIGINAL APPROVAL
1984-05-17
LATEST ACTION
2002-10-25
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued
Products
LIDOCAINE HYDROCHLORIDEDiscontinued
LIDOCAINE HYDROCHLORIDE 2% · INJECTABLE · INJECTION
Approval history
2002-10-25Manufacturing (CMC) · Supplement 23AP
2001-03-22Manufacturing (CMC) · Supplement 22AP
2001-03-22Manufacturing (CMC) · Supplement 21AP
2000-01-07Labeling · Supplement 20AP
2000-01-07Manufacturing (CMC) · Supplement 19AP
1998-05-05Manufacturing (CMC) · Supplement 18AP
1997-01-16Manufacturing (CMC) · Supplement 16AP
1996-11-13Manufacturing (CMC) · Supplement 11AP
1996-11-13Manufacturing (CMC) · Supplement 14AP
1996-11-13Manufacturing (CMC) · Supplement 12AP
1996-11-13Labeling · Supplement 10AP
1996-11-13Manufacturing (CMC) · Supplement 13AP
1996-10-03Manufacturing (CMC) · Supplement 17AP
1990-10-03Labeling · Supplement 7AP
1988-12-23Labeling · Supplement 4AP
1986-08-01Manufacturing (CMC) · Supplement 2AP
1984-05-17OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.